Search
Descriptor English: Mopidamol
Descriptor Spanish: Mopidamol
Descriptor Portuguese: Mopidamol
Descriptor French: Mopidamol
Entry term(s): RA-233
Rapenton
Tree number(s): D03.383.742.430
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D009012
Scope note: A phosphodiesterase inhibitor which inhibits platelet aggregation. Formerly used as an antineoplastic.
Annotation:
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antineoplastic Agents
Registry Number: 4Q0IWP8B8O
CAS Type 1 Name: Ethanol, 2,2',2'',2'''-((4-(1-piperidinyl)pyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-
Previous Indexing: Ethanolamines (1973-1974)
Piperidines (1971-1974)
Pyrimidines (1971-1974)
Public MeSH Note: 91; was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84
Online Note: use MOPIDAMOL to search RA 233 1975-84
History Note: 91(85); was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84
DeCS ID: 9202
Unique ID: D009012
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1974/11/19
Revision Date: 2016/05/31
Mopidamol - Preferred
Concept UI M0014050
Scope note A phosphodiesterase inhibitor which inhibits platelet aggregation. Formerly used as an antineoplastic.
Preferred term Mopidamol
Rapenton - Narrower
Concept UI M0374383
Preferred term Rapenton
RA-233 - Narrower
Concept UI M0374384
Preferred term RA-233



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey